V12 Investment
Pricing for scientific diligence workflows
V12 Pricing
Pricing for biotech scientific diligence
All plans include access to Analyze.
Runs are shared across the platform, so you can move between structured investment-oriented diligence
and faster plausibility review within a single plan.
Trial
For first-time users who want to test V12 on real scientific and therapeutic questions without a subscription.
10 runs included
What you get
- Access to Analyze
- Mechanistic plausibility analysis
- Evidence strength mapping
- Translation risk diagnostics
Most Popular
Plus
For individual analysts, founders, and biotech operators who need recurring scientific diligence support.
100 runs / month
What you get
- Access to Analyze
- Structured diligence output
- Recurring therapeutic evaluation workflow
- Best for individual professional use
Pro
For funds, biotech teams, and professional workflows that require frequent or continuous usage.
Unlimited runs
What you get
- Access to Analyze
- Unlimited scientific diligence workflows
- Designed for professional research usage
- Best for high-volume environments
Go Pro
For professional and team-scale usage.
Built for high-value scientific questions
V12 is designed for biotech scientific diligence workflows, where each run helps evaluate mechanism plausibility,
evidence strength, translational risk, and investment relevance with structured output.
FAQ
What is a run?
A run is one completed analysis request inside V12. Runs can be used across Analyze.
Does Trial renew automatically?
No. Trial is a one-time purchase and does not auto-renew.
Do all plans include both modules?
Yes. Trial, Plus, and Pro all include access to Analyze.
What happens if I use all runs in Plus?
You can upgrade to Pro or wait until the next monthly billing cycle.